Lobbying disclosures · Lobbying report
COR: second_quarter 2026 lobbying report
Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement. Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).
Follow COR- Became public
- Jul 16, 2026, 11:37 AM EDT
- Event / period date
- Not stated
- Collected
- Nov 9, 2026, 11:00 PM EST
Why this is connected
Exact legal-name match: Cencora, Inc. (https://www.sec.gov/Archives/edgar/data/1140859/).
Reported lobbying amounts
Income: $60,000.00
These are different reporting measures. They are not added together or treated as spending on one particular bill.
Source evidence
Read the source excerpt or record
{"url":"https://lda.gov/api/v1/filings/fac61e73-e378-4ccd-afa6-c83e1312485b/","filing_uuid":"fac61e73-e378-4ccd-afa6-c83e1312485b","filing_type":"Q2","filing_type_display":"2nd Quarter - Report","filing_year":2026,"filing_period":"second_quarter","filing_period_display":"2nd Quarter (Apr 1 - June 30)","filing_document_url":"https://lda.gov/filings/public/filing/fac61e73-e378-4ccd-afa6-c83e1312485b/print/","filing_document_content_type":"text/html","income":"60000.00","expenses":null,"expenses_method":null,"expenses_method_display":null,"posted_by_name":"William Moschella, Attorney at Law","dt_posted":"2026-07-16T11:37:11-04:00","termination_date":null,"registrant_country":"United States of America","registrant_ppb_country":"United States of America","registrant_address_1":"600 Massachusetts Ave, NW","registrant_address_2":"Suite 400","registrant_different_address":false,"registrant_city":"Washington","registrant_state":"DC","registrant_zip":"20001","registrant":{"id":7257,"url":"https://lda.gov/api/v1/registrants/7257/","house_registrant_id":31842,"name":"BROWNSTEIN HYATT FARBER SCHRECK, LLP","description":"Law firm","address_1":"600 Massachusetts Ave, NW","address_2":"Suite 400","address_3":null,"address_4":null,"city":"Washington","state":"DC","state_display":"District of Columbia","zip":"20001","country":"US","country_display":"United States of America","ppb_country":"US","ppb_country_display":"United States of America","contact_name":"QUINN MCKAY","contact_telephone":"+1 202-872-5292","dt_updated":"2026-07-30T12:03:37.302760-04:00"},"client":{"id":56963,"url":"https://lda.gov/api/v1/clients/56963/","client_id":56963,"name":"CENCORA, INC.","general_description":"Pharmaceutical wholesale distribution company","client_government_entity":null,"client_self_select":false,"state":"DC","state_display":"District of Columbia","country":"US","country_display":"United States of America","ppb_state":"CO","ppb_state_display":"Colorado","ppb_country":"US","ppb_country_display":"United States of America","effective_date":"2023-07-17"},"lobbying_activities":[{"general_issue_code":"PHA","general_issue_code_display":"Pharmacy","description":"Recognizing pharmacists as providers within Medicare; The Equitable Introduction of Community Access to Pharmacist Services Act Medicare reimbursement.","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":70425,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"FELDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143000,"prefix":null,"prefix_display":null,"first_name":"DEEMA","nickname":null,"middle_name":null,"last_name":"TARAZI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103206,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"STEINMETZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142877,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"SUNSTRUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":61089,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"PFISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150555,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":"ALEXANDRA","last_name":"MISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]},{"general_issue_code":"HCR","general_issue_code_display":"Health Issues","description":"Drug Shortages; supply chain resiliency; PAHPA Reauthorization; Drug Supply Chain Security Act (DSCSA) Implementation, SUPPORT Act Reauthorization, Appropriations bills (FDA, Labor, HHS).","foreign_entity_issues":"","lobbyists":[{"lobbyist":{"id":61089,"prefix":null,"prefix_display":null,"first_name":"ZACHARY","nickname":null,"middle_name":null,"last_name":"PFISTER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":143000,"prefix":null,"prefix_display":null,"first_name":"DEEMA","nickname":null,"middle_name":null,"last_name":"TARAZI","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":103206,"prefix":null,"prefix_display":null,"first_name":"ADAM","nickname":null,"middle_name":null,"last_name":"STEINMETZ","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":150555,"prefix":"ms","prefix_display":"MS.","first_name":"LAUREN","nickname":null,"middle_name":"ALEXANDRA","last_name":"MISH","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":70425,"prefix":null,"prefix_display":null,"first_name":"EMILY","nickname":null,"middle_name":null,"last_name":"FELDER","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":142877,"prefix":null,"prefix_display":null,"first_name":"GREGORY","nickname":null,"middle_name":null,"last_name":"SUNSTRUM","suffix":null,"suffix_display":null},"covered_position":null,"new":false},{"lobbyist":{"id":139943,"prefix":null,"prefix_display":null,"first_name":"ANDREW","nickname":null,"middle_name":null,"last_name":"USYK","suffix":null,"suffix_display":null},"covered_position":null,"new":false}],"government_entities":[{"id":136,"name":"Centers For Medicare and Medicaid Services (CMS)"},{"id":34,"name":"Health & Human Services, Dept of (HHS)"},{"id":2,"name":"HOUSE OF REPRESENTATIVES"},{"id":1,"name":"SENATE"}]}],"conviction_disclosures":[],"foreign_entities":[],"affiliated_organizations":[]}Congressional trading in COR
These disclosures provide context. Their presence does not establish a link between a trader and the event.
- Nov 5, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Oct 7, 2026 · disclosed Nov 5, 2026 · Spouse
Traded 14 days before earnings - Oct 7, 2026$1K–$15K
Rep. Ro Khanna (D-CA-17)
$1K–$15K · Traded Sep 4, 2026 · disclosed Oct 7, 2026 · Spouse
- Jul 21, 2026$1K–$15K
Sen. Alan Armstrong (R-OK)
$1K–$15K · Traded Mar 27, 2026 · disclosed Jul 21, 2026 · filed 116 days later
Committee overlap: HELP - Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026
Got $1K from the company’s PAC - Jun 19, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded May 6, 2026 · disclosed Jun 19, 2026 · Dependent
Got $1K from the company’s PAC - Apr 30, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 31, 2026 · disclosed Apr 30, 2026
Got $1K from the company’s PAC - Apr 30, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 23, 2026 · disclosed Apr 30, 2026
Got $1K from the company’s PAC - Apr 30, 2026$1K–$15K
Rep. Jared Moskowitz (D-FL-23)
$1K–$15K · Traded Mar 23, 2026 · disclosed Apr 30, 2026 · Dependent
Got $1K from the company’s PAC
Original documents control. Public records can be amended, and company connections may require interpretation. Nothing here is investment advice.